Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient

AstraZeneca

Status: Completed

Conditions: Asthma

Treatments: Other: 2; Other: 1

Study type: Observational

Funder types: Industry

Identifiers

NCT01085474

NIS-RES-DUM-2009/1

Details and patient eligibility

About

Measurement of disease control, treatment adherence and patient knowledge of his/her medication in patients that are receiving a pharmaceutical intervention compared with those patients who receive regular pharmaceutical care.

Enrollment: 384 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who have given their informed consent and expressed interest in participating in the study
• Asthmatic Patients

Exclusion criteria

• Patients with communication difficulties.
• Persons who obtain symbicort but not for their own use.
• Patients with other major diseases: Heart problems, COPD, EMPHYSEMA, lung cancer, AIDS.
• Patients with a respiratory infection.
• Patients with seasonal asthma.
• Pregnant women
• Patients who have previously participated in a health education study in asthma.

Trial design

384 participants in 2 patient groups

1

Description:

1. Pilot Study: 60 patients (all in the intervention group) 30 patients with intervention A and 30 patients with B intervention)

Treatment:

Other: 1

2

Description:

Main Study: 600 patients (30 pharmacies control group and 30 pharmacies intervention group, 10 patients per pharmacy)

Treatment:

Other: 2